miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinomaKai Liu(Nanchang University), Yahui Liu(Jilin University)International Journal of OncologyAugust 4, 201410.3892/ijo.2014.2577Cited by 48SaveCiteExport RISWatch citationsRelated PapersmiR-363 inhibits the growth, migration and invasion of hepatocellular carcinoma cells by regulating E2F3|Oncology Reports|2017|22Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo|Oncology Reports|2014|21